Fundamentals Overview
Amgen Inc. is in the middle of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+194% upside vs price
Profitability
Risk (Beta)
0.4 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +194% upside vs price · Analyst grade: B+
Pressures (Sell):
Sentiment weakening (2 downgrades) · 3M vs S&P 500: -8% · 3M vs Healthcare sector: -5.4%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 3, Equal Weight: 7, Hold: 5, Market Perform: 1, Neutral: 8, Outperform: 3, Overweight: 3.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $1,044.49; current price is $355.25. That’s a +194% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 24.78 |
| DCF value (model) | $1,044.49 (194% upside) |
| PEG (TTM) | 0.79 |
| P/B (TTM) | 20.87 |
| P/S (TTM) | 5.15 |
| P/FCF (TTM) | 22.3 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.26 |
| Quick Ratio (TTM) | 1.01 |
| Cash Ratio (TTM) | 0.48 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 20.95% |
| Gross margin (TTM) | 71.46% |
| Operating margin (TTM) | 31.63% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for AMGN.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-07-08 |
| Truist Securities | maintain | Hold | Hold | 2026-07-07 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2026-07-06 |
| Mizuho | maintain | Neutral | Neutral | 2026-06-16 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-06-10 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-05-14 |
| Guggenheim | maintain | Neutral | Neutral | 2026-05-04 |
| Truist Securities | maintain | Hold | Hold | 2026-05-01 |
| UBS | maintain | Buy | Buy | 2026-04-13 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-04-10 |
| Guggenheim | maintain | Neutral | Neutral | 2026-04-09 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2026-04-08 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-19 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-18 |
| Freedom Broker | downgrade | Buy | Hold | 2026-02-12 |
| Argus Research | maintain | Buy | Buy | 2026-02-06 |
| Guggenheim | maintain | Neutral | Neutral | 2026-02-06 |
| Citigroup | maintain | Neutral | Neutral | 2026-02-04 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-02-04 |
| Leerink Partners | maintain | Outperform | Outperform | 2026-02-04 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2026-02-04 |
| UBS | maintain | Buy | Buy | 2026-01-26 |
| Bernstein | downgrade | Outperform | Market Perform | 2026-01-20 |
| Truist Securities | maintain | Hold | Hold | 2026-01-08 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-12-12 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-12-10 |
| BMO Capital | maintain | Outperform | Outperform | 2025-12-03 |
| Leerink Partners | maintain | Outperform | Outperform | 2025-11-27 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-11-14 |
| Freedom Broker | maintain | Hold | Hold | 2025-11-12 |